These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25258530)
1. Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites. Gao J; Xue JF; Xu M; Gui BS; Wang FX; Ouyang JM Int J Nanomedicine; 2014; 9():4399-409. PubMed ID: 25258530 [TBL] [Abstract][Full Text] [Related]
2. Component analyses of urinary nanocrystallites of uric acid stone formers by combination of high-resolution transmission electron microscopy, fast Fourier transformation, energy dispersive X-ray spectroscopy, X-ray diffraction and Fourier transform infrared spectroscopy. Sun XY; Xue JF; Xia ZY; Ouyang JM IET Nanobiotechnol; 2015 Jun; 9(3):114-21. PubMed ID: 26023155 [TBL] [Abstract][Full Text] [Related]
3. [Components of Urinary Nanocrystals and Their Influence on Formation of Calcium Oxalate Stones]. Li YB; Wen XL; Xue JF; Ouyang JM Guang Pu Xue Yu Guang Pu Fen Xi; 2015 Aug; 35(8):2257-62. PubMed ID: 26672305 [TBL] [Abstract][Full Text] [Related]
4. Changes in urinary nanocrystallites in calcium oxalate stone formers before and after potassium citrate intake. Duan CY; Xia ZY; Zhang GN; Gui BS; Xue JF; Ouyang JM Int J Nanomedicine; 2013; 8():909-18. PubMed ID: 23467267 [TBL] [Abstract][Full Text] [Related]
5. Role of the urinary calcium in the growth of calcium stone. Murayama T; Sakai N; Takano T; Yamada T Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887 [TBL] [Abstract][Full Text] [Related]
6. Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of healthy persons and lithogenic patients. He JY; Deng SP; Ouyang JM IEEE Trans Nanobioscience; 2010 Jun; 9(2):156-63. PubMed ID: 20423812 [TBL] [Abstract][Full Text] [Related]
7. [The property changes of urine crystallites of calcium oxalate stone formers before and after taking medicine]. Li JJ; Hou SH; Xia ZY; Ouyang JM Guang Pu Xue Yu Guang Pu Fen Xi; 2011 Aug; 31(8):2263-7. PubMed ID: 22007430 [TBL] [Abstract][Full Text] [Related]
8. [XRD, FTIR and thermoluminescence spectra of different types of urinary stones]. Yang J; He JY; Ouyang JM Guang Pu Xue Yu Guang Pu Fen Xi; 2011 Aug; 31(8):2268-73. PubMed ID: 22007431 [TBL] [Abstract][Full Text] [Related]
9. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis. Karagülle O; Smorag U; Candir F; Gundermann G; Jonas U; Becker AJ; Gehrke A; Gutenbrunner C World J Urol; 2007 Jun; 25(3):315-23. PubMed ID: 17333204 [TBL] [Abstract][Full Text] [Related]
10. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084 [TBL] [Abstract][Full Text] [Related]
11. Property changes of urinary nanocrystallites and urine of uric acid stone formers after taking potassium citrate. Zhang GN; Ouyang JM; Xue JF; Shang YF Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4039-45. PubMed ID: 23910312 [TBL] [Abstract][Full Text] [Related]
12. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein. Schwille PO; Schmiedl A; Manoharan M Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561 [TBL] [Abstract][Full Text] [Related]
13. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis. Grover PK; Kim DS; Ryall RL Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569 [TBL] [Abstract][Full Text] [Related]
14. [Components of urinary crystallites in urine of uric acid stone formers and its relationship with formation of stones]. Huang ZJ; Tan J; Ouyang JM Guang Pu Xue Yu Guang Pu Fen Xi; 2010 Sep; 30(9):2350-4. PubMed ID: 21105393 [TBL] [Abstract][Full Text] [Related]
15. In vitro formation of "urinary stones": generation of spherulites of calcium phosphate in gel and overgrowth with calcium oxalate using a new flow model of crystallization. Achilles W; Jöckel U; Schaper A; Burk M; Riedmiller H Scanning Microsc; 1995 Jun; 9(2):577-85; discussion 585-6. PubMed ID: 8714750 [TBL] [Abstract][Full Text] [Related]
16. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients. Murayama T; Sakai N; Yamada T; Takano T Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477 [TBL] [Abstract][Full Text] [Related]
17. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation. Schwille PO; Schmiedl A; Wipplinger J Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857 [TBL] [Abstract][Full Text] [Related]
18. [Study on nano- and microcrystallites in the urines of calcium oxalate stone formers]. Huang ZJ; Li JJ; He JY; Ouyang JM Guang Pu Xue Yu Guang Pu Fen Xi; 2010 Jul; 30(7):1913-7. PubMed ID: 20827998 [TBL] [Abstract][Full Text] [Related]
19. FT-IR spectral studies on certain human urinary stones in the patients of rural area. Selvaraju R; Thiruppathi G; Raja A Spectrochim Acta A Mol Biomol Spectrosc; 2012 Jul; 93():260-5. PubMed ID: 22484261 [TBL] [Abstract][Full Text] [Related]
20. Systemic analysis of urinary stones from the Northern, Eastern, Central, Southern and Southwest China by a multi-center study. Ma RH; Luo XB; Li Q; Zhong HQ BMC Urol; 2018 Dec; 18(1):114. PubMed ID: 30545321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]